Boeing reported Q3 2026 revenue of $24.19 billion, beating estimates of $23.84 billion. But adjusted core earnings per share came in at -$0.34, worse than the -$0.21 loss consensus expected. This is the miss that matters.
The commercial airplanes division posted a $697 million operating loss—a direct hemorrhage on the bottom line. Negative 6.5 percent operating margin. That's where the damage is real, and it's where investors need to focus.
Boeing is targeting 737 production of 47 aircraft per month and holding 787 Dreamliner output at eight monthly. The 737 ramp is not aspirational. It's the make-or-break operational metric. Miss it, and you're looking at restructuring charges, cash flow deterioration, and another round of guidance cuts. Hit it consistently, and you've got a path to positive momentum in 2027.
The rest of the company is pulling its weight. Global Services hit 18.3 percent operating margin. Defense, Space & Security posted 6.2 percent. Those segments are intact. But commercial is the earnings driver, and commercial is broken right now.
Boeing generated $464 million in free cash flow this quarter despite the operating loss, and the backlog sits at $745 billion. That's real optionality—if execution improves. The question isn't backlog. It's whether Boeing can convert backlog into deliveries at acceptable margins while managing supply chain chaos.
Watch the Q4 2026 earnings call in late January 2027. Scrutinize supply chain health commentary, any revised full-year guidance, and whether management maintains the 737 production cadence or flags new risks. If the 47-per-month target slips again, the stock reprices lower. If Boeing holds the line on production and shows improving margins, you've got a recovery play.
